Review Paper | 2025 | Volume 1 | Issue 1 | Page 40-49 Dr. Abhisekh Gangauly, Lecturer, Department of Cardiology, IPGMER, Kolkata Abstract The traditional practice of Percutaneous Coronary Intervention (PCI) is currently undergoing a dual transformation, shifting from manual, tactile-dependent maneuvers to a high-precision, digitalized framework. This review evaluates the clinical and technical convergence of Robotic-Assisted PCI (R-PCI) and Artificial Intelligence (AI), a syn

Review Paper | 2025 | Volume 1 | Issue 1 | Page 17-25 Dr. Amrish Singh, Lecturer, Department of Genetics, SNS College, Nawada Abstract As we approach the 2030 threshold, the paradigm of interventional cardiology is shifting from mechanical restoration to biological rejuvenation. The final frontier of "NextGen" cardiology lies in the integration of Nanotechnology and Gene Therapy, moving beyond the macro-scale of stents and valves into the sub-cellular environment. This chapte

Review Paper | 2026 | Volume 2 | Issue 1 | Page 84-88 Dr. Abhimita Singh, Professor, Cardiology, JMCH, Jalgwao, MP Abstract While mechanical and robotic innovations have redefined the physical landscape of the catheterization lab, the success of these procedures remains inextricably linked to advanced Pharmacotherapy. The "NextGen" era of intervention is not just about the hardware of stents and valves, but the biological management of the blood-surface interface. This chapte

Review Paper | 2026 | Volume 2 | Issue 1 | Page 78 - 83 Dr. Amali Singh Tanuja, Assistant Professor, Department of Cardiology, GMC, Sis UP Abstract The clinical landscape of interventional cardiology is increasingly defined by the CHIP (Complex High-Risk Indicated Patient) population—a cohort characterized by complex coronary anatomy, severe hemodynamic compromise, and multiple systemic comorbidities. Historically, these patients were often deemed "inoperable" or "un-treatab

Review Paper | 2026 | Volume 2 | Issue 1 | Page 67 - 72 Dr. SK Singh, Assistant Professor, Department of Cardiology, BSMCH, Bangladesh Abstract The management of structural heart disease (SHD) has undergone a seismic shift, moving from highly invasive surgical repairs to sophisticated, catheter-based interventions. While Transcatheter Aortic Valve Replacement (TAVR) served as the proof-of-concept for this revolution, recent innovations have extended these "NextGen" therapies